rheumatoid arthritis

researchers-develop-first-in-class-antibodies-to-combat-autoimmune-inflammation

Researchers Develop First-in-Class Antibodies to Combat Autoimmune Inflammation

Editorial 19 November, 2025

An international collaboration led by researchers at UMC Utrecht has successfully developed two first-in-class...

johnson-johnson-s-imaavy-fails-key-study-puts-future-at-risk

Johnson & Johnson’s Imaavy Fails Key Study, Puts Future at Risk

Editorial 29 August, 2025

Johnson & Johnson’s newly-approved drug, Imaavy, has encountered a significant setback after failing to...